Sara Johnson
Rheumatology · Smithtown, NYNPI 1043206964
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 561 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,423 and has fallen 99.1% since, to $29 in 2025.
Across 561 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Johnson & Johnson$1K
- AbbVie$1K
- Pfizer$1K
- UCB, Inc.$628
- Lilly USA, LLC$584
- plus $4K from 24 others
What the payments were for
- Food & beverage$10,40099%
- Education$1551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 94 | $1,860 |
| Johnson & Johnson(2 entities) | 64 | $1,500 |
| AbbVie | 57 | $1,117 |
| Pfizer | 85 | $1,021 |
| UCB, Inc. | 43 | $628 |
| Lilly USA, LLC | 29 | $584 |
| Novartis | 35 | $530 |
| AstraZeneca(2 entities) | 19 | $381 |
| Genentech USA, Inc. | 20 | $377 |
| GSK | 14 | $315 |
| Radius Health, Inc. | 15 | $306 |
| Regeneron Healthcare Solutions, Inc. | 10 | $268 |
| Aurinia Pharma U.S., Inc. | 14 | $254 |
| Mallinckrodt Enterprises LLC | 10 | $234 |
| Pacira Therapeutics, Inc. | 5 | $177 |
| Boehringer Ingelheim | 6 | $156 |
| Sobi, Inc | 5 | $106 |
| ANI Pharmaceuticals, Inc. | 4 | $105 |
| Bristol Myers Squibb | 4 | $89 |
| Mallinckrodt Hospital Products Inc. | 3 | $83 |
| Antares Pharma, Inc. | 3 | $63 |
| Ferring Pharmaceuticals Inc. | 3 | $61 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| Merck | 3 | $51 |
| Hikma Pharmaceuticals USA | 3 | $47 |
| Fidia Pharma USA Inc. | 4 | $47 |
| Sanofi | 1 | $34 |
| Incyte Corporation | 1 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
How this compares
$10,554 in reported general payments places this provider in the 75th percentile of 541 rheumatology providers in New York.
Other rheumatology in Smithtown
- Howard BlumsteinSmithtown$56K
- Paul SchulmanSmithtown$54K
- Daniel Torres LeyvaSmithtown$47K
- Laurie GlimcherNew York$3.9M
- Grace WrightNew York$3M
- Kostas BotsoglouCheektowaga$2.6M
- Sergio SchwartzmanNew York$2.5M
- Allan GibofskyNew York$1.9M
- Petros EfthimiouNew York$791K
- Richard FurieNew Hyde Park$746K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.